Citigroup’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $304K | Sell |
15,280
-14,452
| -49% | -$287K | ﹤0.01% | 3162 |
|
2025
Q1 | $502K | Sell |
29,732
-6,735
| -18% | -$114K | ﹤0.01% | 2944 |
|
2024
Q4 | $674K | Buy |
36,467
+3,375
| +10% | +$62.3K | ﹤0.01% | 2833 |
|
2024
Q3 | $719K | Buy |
33,092
+10,236
| +45% | +$222K | ﹤0.01% | 2777 |
|
2024
Q2 | $448K | Buy |
22,856
+2,173
| +11% | +$42.6K | ﹤0.01% | 2768 |
|
2024
Q1 | $449K | Buy |
20,683
+6,406
| +45% | +$139K | ﹤0.01% | 2925 |
|
2023
Q4 | $413K | Buy |
14,277
+4,739
| +50% | +$137K | ﹤0.01% | 2824 |
|
2023
Q3 | $255K | Sell |
9,538
-6,418
| -40% | -$172K | ﹤0.01% | 2854 |
|
2023
Q2 | $591K | Buy |
15,956
+5,103
| +47% | +$189K | ﹤0.01% | 2622 |
|
2023
Q1 | $339K | Sell |
10,853
-4,856
| -31% | -$152K | ﹤0.01% | 2805 |
|
2022
Q4 | $468K | Buy |
15,709
+4,847
| +45% | +$144K | ﹤0.01% | 2580 |
|
2022
Q3 | $414K | Buy |
10,862
+610
| +6% | +$23.3K | ﹤0.01% | 2710 |
|
2022
Q2 | $559K | Sell |
10,252
-9,900
| -49% | -$540K | ﹤0.01% | 2513 |
|
2022
Q1 | $1.26M | Buy |
20,152
+702
| +4% | +$43.8K | ﹤0.01% | 2135 |
|
2021
Q4 | $1.96M | Buy |
19,450
+606
| +3% | +$60.9K | ﹤0.01% | 1988 |
|
2021
Q3 | $1.7M | Buy |
18,844
+366
| +2% | +$32.9K | ﹤0.01% | 2030 |
|
2021
Q2 | $1.7M | Buy |
18,478
+16,960
| +1,117% | +$1.56M | ﹤0.01% | 2204 |
|
2021
Q1 | $147K | Sell |
1,518
-1,774
| -54% | -$172K | ﹤0.01% | 3532 |
|
2020
Q4 | $172K | Buy |
3,292
+2,827
| +608% | +$148K | ﹤0.01% | 3320 |
|
2020
Q3 | $19K | Sell |
465
-872
| -65% | -$35.6K | ﹤0.01% | 3988 |
|
2020
Q2 | $21K | Sell |
1,337
-523
| -28% | -$8.22K | ﹤0.01% | 4212 |
|
2020
Q1 | $20K | Buy |
1,860
+912
| +96% | +$9.81K | ﹤0.01% | 4359 |
|
2019
Q4 | $12K | Buy |
+948
| New | +$12K | ﹤0.01% | 4658 |
|
2017
Q2 | – | Sell |
-171
| Closed | -$2K | – | 4896 |
|
2017
Q1 | $2K | Sell |
171
-22,709
| -99% | -$266K | ﹤0.01% | 4636 |
|
2016
Q4 | $265K | Buy |
+22,880
| New | +$265K | ﹤0.01% | 3404 |
|